Pharmaceuticals, Biotechnology and Life Sciences
Vertex got a deal with NHS England, to enable eligible patients with cystic fibrosis in England the access to Orkambi…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), has completed patient enrollment in its Phase 2 clinical trial of AR-1105 in…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter…
ICON has acquired Symphony Clinical Research, to boost its ability to offer customers hybrid trial solutions and site support services,…
Janssen has submitted a type II variation application to European Medicines agency, looking to get approved guselkumab, which could then…
The CoFI™ System is indicated for diagnostic assessment of the coronary microcirculation immediately following PCI (“stenting”), and to be a…
Hemogenyx Pharmaceuticals has signed a research agreement through is subsidiary Immugenyx, to develop humanized mice as a tool for drug development and testing, including with a global pharmaceutical company, whose identity must remain hidden at its request.
NOTTINGHAM, England–(BUSINESS WIRE)–Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non-executive…
Bicycle is going to collaborate with ODDI, an organization with deep expertise in the molecular pathology of Alzheimer’s disease and…
Takeda got exclusive global license for investigational medicine CNP-101/TAK-101, an immune modifying nanoparticle designed to induce tolerance to gluten in…